Masculinizing hormone therapy

Masculinizing hormone therapy is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender and gender diverse individuals for the purpose of aligning their secondary sexual characteristics more closely with their gender identity. This form of hormone therapy is typically given to individuals assigned female at birth who identify as male or on the masculine spectrum.

Overview

Masculinizing hormone therapy primarily involves the administration of testosterone, a hormone that is responsible for the development of male secondary sexual characteristics. The therapy may be administered in several forms, including injections, patches, gels, and tablets. The specific form and dosage of testosterone used may vary depending on the individual's health, age, and personal preference.

Effects

The effects of masculinizing hormone therapy can be both physical and psychological. Physical changes may include increased muscle mass, redistribution of body fat, deepening of the voice, growth of facial and body hair, cessation of menstruation, and enlargement of the clitoris. Psychological changes may include increased libido, changes in emotional well-being, and changes in social identity and interactions.

Risks and considerations

Like all forms of hormone therapy, masculinizing hormone therapy carries potential risks and side effects. These may include acne, mood changes, weight gain, increased red blood cell count, and potential cardiovascular risks. Long-term effects of the therapy are not fully known, and ongoing medical monitoring is recommended.

See also

• Feminizing hormone therapy
• Transgender health care
• Gender dysphoria
• Hormone replacement therapy (transgender)

Masculinizing hormone therapy

• 
  Depo-testosterone 200 mg/ml